期刊文献+

各类指南对膳食胆固醇摄入量建议的回顾

Review of recommendations for dietary intake of cholesterol based on various guidelines
原文传递
导出
摘要 近年来,关于膳食胆固醇到底该吃多少有诸多争论,本文回顾了自20世纪中叶以来一些国家及国际相关组织的膳食指南、建议及策略,对膳食胆固醇部分进行了梳理,就一般人群和特殊人群的膳食胆固醇摄入量及其建议进行解读,以期能帮助专业人员及公众更好地理解指南的含义,消除对膳食胆固醇以偏概全的认识,树立平衡健康的饮食观念。 In recent years, there is much debate on how much cholesterol should be taken in with diet. This article reviews the dietary guidelines, recommendations, and strategies of some national and international organizations since the mid-20th century. The dietary cholesterol was systematically combed and interpreted on its intake for the general population and special population. We would like to help the professionals and public better understand the meaning of the guidelines, to eliminate the misunderstanding of dietary cholesterol and to establish the correct concept of healthy eating pattern.
作者 刘丹 赵文华
出处 《中华健康管理学杂志》 CAS 2017年第1期29-33,共5页 Chinese Journal of Health Management
关键词 胆固醇 膳食 脂肪酸类 不饱和 膳食指南 膳食模式 Cholesterol, dietary Fatty acids, unsaturated Dietary guidelines Dietary pattern
  • 引文网络
  • 相关文献

参考文献6

二级参考文献37

  • 1中国成人血脂异常防治指南制定联合委员会.中国成人血脂异常防治指南.中华心血管病杂志,2001,29:315-317.
  • 2Stone NJ,Robinson J,Lichtenstein AH,et al.2013 ACC/AHA Guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults:a report of the American College of Cardiology/American Heart Association task force on practice guidelines[J].Circulation,2013,pii:S0735-1097 (13)06028-2.
  • 3Scandinavian simvastatin survival study group.Randomised trial of lowering in 4444 patients with coronary heart disease:the Scandinavian simvastatin survival study (4S)[J].Lancet,1994,344:1383-1389.
  • 4Sharp collaborative group.Study of heart and renal protection (SHARP):randomized trial to assess the effects of lowering lowdensity lipoprotein cholesterol among 9438 patients with chronic kidney disease[J].Am Heart J,2010,160:785-794.e10.
  • 5Baigent C,Blackwell L,Emberson J,et al.Efficacy and safety of more intensive lowering of LDL cholesterol:a meta-analysis of data from 170000 participants in 26 randomised trials[J].Lancet,2010,376:1670-1681.
  • 6FDA Drug Safety Communication:New restrictions,contraindications,and dose limitations for Zocor (simvastatin) to reduce the risk of muscle injury[EB/OL].(2011-06-08)[2014-03-27].http://www.fda.gov/Drugs/DrugSafety/ucm256581.htm.
  • 7The National Lipid Association recommendations for patientcentered treatment of dyslipidemia[EB/OL].(2014-05-20)[2014-05-21].https://www.lipid.org/nla/recommendationspatient-centered-management-dyslipidemia.
  • 8Cannon CP,Braunwald E,McCabe CH,et al.Intensive versus moderate lipid lowering with statins after acute coronary syndromes[J].N Engl J Med,2004,350:1495-1504.
  • 9HPS2-THRIVE Collaborative Group.HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant:trial design,pre-specified muscle and liver outcomes,and reasons for stopping study treatment[J].Eur Heart J,2013,34:1279-1291.
  • 10WHO/FAO Preparation and use of food-based dietary guidelines.Joint FAO/WHO Consultation.WHO Technical Report Series 880,Geneva:WHO,1999

共引文献200

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部